MedTrace Logo

Hyponatremia - Complications, Prognosis, Epidemiology in Finnish Tertiary Care

NCT07430787 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 10000

Last updated 2026-02-24

No results posted yet for this study

Summary

Study Objectives and Hypothesis

To determine the incidence of hyponatremia at TYKS and the factors associated with it.

To assess how rapidly hyponatremia was corrected and how the rate of correction affected patient prognosis.

To evaluate treatment modalities and their impact on patient prognosis, length of hospital stay, and their appropriateness in comparison with national and international treatment guidelines.

To determine the incidence of osmotic demyelination at TYKS and the factors associated with it.

To assess other complications and their clinical significance.

To evaluate the impact of hyponatremia on various endpoints, such as mortality, length of hospital stay, seizures, confusion, and similar outcomes.

Conditions

Sponsors & Collaborators

  • University of Turku

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-09-01
Primary Completion
2026-01-01
Completion
2028-12-31

Countries

  • Finland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07430787 on ClinicalTrials.gov